IsraelLawA foreign investor funds an Israeli company and is then asked to take a board seat, or to nominate someone they trust to take one. The careful version of the question that follows is rarely about the role itself. It is "what happens to me, personally, if this goes wrong?" In Israel the answer comes down to three protections built into the Companies Law, and to whether the company has actually put them in place. Plenty have not, or have done it on paper only.
This guide explains how an Israeli company shields a director or officer from personal exposure, where the law draws hard limits that no amount of drafting can cross, and what a foreign director should confirm before signing a consent to act. One point of vocabulary matters from the start: Israeli law does not protect "directors" as a special class. It protects the broader category of nosse misra, an "office holder," which the Companies Law defines to include directors, the general manager (CEO), and other senior managers who report to them.
1. Overview: Why This Protection Exists
Directors and officers in Israel carry real personal duties to the company, not ceremonial ones. The Companies Law imposes a duty of care under Sections 252 and 253, borrowing the standard of a reasonable office holder in the same position, and a duty of loyalty under Section 254, which requires the officer to act in good faith and for the company's benefit. Break either and you can be sued in your own name, with your own assets on the line.
The routes to that exposure are wider than newcomers expect. The company itself can sue. So can a shareholder, through a derivative claim brought on the company's behalf under Sections 194 to 205, and increasingly through class actions. Regulators and the courts can pile on civil and even criminal proceedings. A director who joined "as a favour" can find themselves named in a claim years later over a board decision they barely remember. Exemption, indemnification, and insurance exist to put a buffer between that risk and the individual, within the boundaries the legislature was willing to allow.
When a foreign director has an Israeli board appointment vetted, the first document to request is never the appointment letter. It is the company's articles, the existing D&O policy and its limit, and the indemnification undertaking the company intends to give. If those three do not exist, the director should make their creation a condition of accepting, in writing, before signing anything. A director's signature on a consent to act is effective immediately; the protection often takes a board meeting, a shareholder resolution, and an insurer's quote to put in place. Closing that gap after you have already joined is far harder than closing it as a precondition.
2. The Three Pillars: Exemption, Indemnification, Insurance
Israeli law gives a company three distinct tools, and they are not interchangeable. Understanding what each one does, and what it cannot do, is the whole game.
- Exemption (petor): the company waives, in advance, its own right to sue the officer for damage caused by a breach of the duty of care. It only protects against claims by the company itself, and only for negligence.
- Indemnification (shipui): the company agrees to reimburse the officer for money they are ordered to pay and for reasonable legal costs. This can be promised in advance or granted after a claim arises.
- Insurance (bituach): the company buys a D&O policy from an insurer that pays defence costs and liabilities on the officer's behalf. The insurer, not the company, carries the financial risk.
In a well-structured company the three work as layers. The insurance policy responds first and does the heavy lifting. Indemnification by the company sits behind it, catching what the policy does not cover or amounts above a deductible. Exemption is the thinnest layer and the least used. Each pillar needs its own foundation in the articles and its own approval.
Indemnification is only as good as the company's bank balance on the day you need it. If the company has collapsed, which is exactly when directors get sued, an indemnification undertaking from an insolvent company is worth very little. That is why the D&O policy is the real protection and the indemnification undertaking is the backstop. When reviewing terms for a director, most of the attention belongs on the policy: the limit, the exclusions, who controls the defence, and whether defence costs are advanced as the case runs rather than reimbursed only after it ends.
3. What Can Never Be Covered
Before the mechanics, the limits, because they decide how much comfort any of this really buys. Section 263 of the Companies Law makes a provision in the articles void to the extent it tries to indemnify, insure, or exempt an officer for liability arising from any of the following:
- A breach of the duty of loyalty, unless the officer acted in good faith and had reasonable grounds to believe the act would not harm the company. Outside that narrow good-faith carve-out, disloyalty is simply not coverable.
- A breach of the duty of care committed intentionally or recklessly. Plain negligence can be covered; deliberate or reckless conduct cannot.
- An act done with intent to make an unlawful personal profit.
- A fine, civil monetary sanction (itzum kaspi), forfeiture, or penalty (kofer) imposed on the officer.
The logic is straightforward. The law lets a company absorb the cost of honest mistakes, so that capable people will agree to serve, but it refuses to let a company underwrite fraud, self-dealing, or punishment that the legal system deliberately aimed at the individual. No clever drafting gets around Section 263, and an undertaking that purports to is void on that point regardless of what the parties signed.
Most disputes do not turn on whether indemnification existed. They turn on which side of the Section 263 line the conduct fell. A director who approved a transaction that turned out badly, but who read the materials and acted in what they honestly believed were the company's interests, is usually on the coverable side. A director who looked away from an obvious conflict, or signed off to benefit a related party, may not be. Keep the evidence of good faith as you go: minutes that record what the board considered, the advice it took, and why it decided as it did. That contemporaneous record is what later separates a covered negligence claim from an uncovered loyalty breach.
4. Exemption From the Duty of Care
Exemption is the simplest pillar and the most limited. Under Section 259, a company whose articles permit it may release an office holder, in advance, from all or part of their liability for damage caused to the company by a breach of the duty of care. Note the boundaries hidden in that sentence. Exemption only covers the duty of care, never the duty of loyalty. And it only protects against claims by the company; it does nothing about a claim by a third party or a regulator.
There is also a specific statutory hole. Section 259(b) bars a company from exempting a director, in advance, from liability for a breach of the duty of care in a distribution (chaluka), meaning a dividend or buy-back. Distributions that fail the solvency and profit tests are one of the classic ways directors incur personal liability in Israel, and the legislature pointedly refused to let companies waive that one away.
A director should rarely rely on the exemption clause for comfort, and here is why. It does nothing against the claims directors most fear, which come from outside the company: a creditor after an insolvency, a shareholder class action, a regulator. Where it does help, the company has chosen to give up its own claim against you, which is useful but narrow. Treat the exemption as a minor extra in the articles, not as a substitute for a real D&O policy. If a company offers you a board seat and points to an exemption clause as your safety net, that is a sign they have not thought the protection through.
5. Indemnification: In Advance and After the Fact
Indemnification is the workhorse. Under Section 260, a company whose articles allow it may reimburse an office holder for a liability or expense imposed on them for an act done in their capacity as an officer. The covered items fall into a few buckets:
- A monetary liability imposed by a judgment, including a settlement or an arbitral award that a court has approved.
- Reasonable litigation costs, including lawyers' fees, that the officer incurs in a proceeding brought against them, whether by the company, by a third party, or in a criminal case that ends in acquittal or in conviction of an offence that does not require criminal intent.
- Reasonable costs of responding to an investigation or proceeding by an authorised body that closes without an indictment, subject to the statutory conditions.
Indemnification comes in two flavours. Retroactive indemnification is decided after a specific claim has already landed. Advance indemnification is a standing undertaking the company gives when the officer joins, promising to cover future claims. Advance cover is what directors actually want, because it is in place before trouble starts. But Section 260(b) puts a leash on it: an advance undertaking for a monetary liability must be limited to types of events the board can foresee given the company's actual activity, and capped at an amount or by criteria the board has decided are reasonable. A blank cheque is not allowed.
Because advance indemnification must be capped, the number in the undertaking is the number that matters. Some undertakings cap total indemnification at an amount that sounds large in isolation but is tiny against the real exposure, for example a fixed figure that ignores how much a securities class action or a creditor claim after insolvency could actually reach. A common market approach ties the cap to a percentage of the company's equity or to a multiple of the D&O policy limit, and lets it sit alongside the insurance rather than overlap it awkwardly. When you review your undertaking, ask the simple question: if the worst realistic claim arrives, does this cap plus the policy actually cover it, or am I exposed for the gap?
6. D&O Insurance and What It Costs
Directors' and officers' liability insurance is the pillar that carries the weight, and Section 261 sets out what an Israeli company may insure: a breach of the duty of care; a breach of the duty of loyalty, but only where the officer acted in good faith and had reasonable grounds to believe the act would not harm the company; and a monetary liability imposed in favour of a third party. For public companies the policy can also extend to certain payments to people harmed by a securities breach under the Securities Law, 5728-1968, within limits.
A few features of how these policies actually work matter more than the headline limit:
- Claims-made, not occurrence. The policy that pays is the one in force when the claim is made, not when the underlying act happened. This is why gaps in cover when a director leaves are dangerous (see Section 8).
- Advancement of defence costs. A good policy pays lawyers as the case proceeds. A weak one reimburses only at the end, which can leave a director funding their own defence for years.
- Territorial and jurisdiction scope. A standard Israeli policy may not respond to a claim filed abroad. For a foreign director, this is the clause to check first.
On cost, expect a wide range and treat any single figure as indicative. For a small private Israeli company with a modest risk profile, a basic policy can start in the low tens of thousands of shekels a year. A venture-backed startup with US investors, US customers, and the securities exposure that comes with them will pay considerably more, sometimes a multiple of that, for a meaningful limit. Premiums are driven by the coverage limit, the company's sector and size, its financing history, and its claims record. Insurers offering these policies in Israel are regulated by the Capital Market, Insurance and Savings Authority (Rashut Shuk HaHon, Bituach veHisachon).
A point directors miss: the policy limit is usually shared across every insured person and often eroded by defence costs. If the company, the CEO, and four directors are all named in one claim, you are not each protected up to the full limit; you are sharing it, and the lawyers' bills are eating into it before any settlement is paid. On a serious matter, legal fees alone can run into the hundreds of thousands of shekels. For a director joining a company with several others on the board, the limit should be measured against the number of people it has to protect at once, not against a single hypothetical claim. If the limit looks thin for the size of the board and the business, the director should push for a higher one or for separate Side A cover that protects individuals when the company cannot indemnify.
7. Who Must Approve It, and Where It Lives
Even a perfect indemnification undertaking is worthless if it was not approved correctly. Israeli law treats exemption, indemnification, and insurance for officers as transactions in the officer's terms of office, which triggers a defined approval path. Two foundations have to be in place.
First, the articles of association must permit the protection. Sections 259 to 261 each begin with the condition "if the articles so allow." A company whose articles are silent has to amend them before it can grant any of the three. Amending the articles is a shareholder decision, and a change must be reported to the Registrar of Companies within 14 days under the notice rules of the Companies Law.
Second, the specific terms have to be approved by the right organs:
- For an officer who is not a director, board approval is generally enough in a private company (with the audit or compensation committee involved where the company has one).
- For a director, the terms ordinarily need approval by the board and by the shareholders in general meeting. In a public company, the compensation committee approves first, and the terms must fit within the company's compensation policy.
That compensation policy is its own requirement. Under Section 267A, a public company must adopt a policy governing the terms of office of its officers, including their insurance and indemnification, approved by the compensation committee, the board, and the general meeting, and revisited at least once every three years. A private company has no such obligation, which is one of the few areas where private companies have an easier path.
The order of operations protects you. The articles should be amended, the indemnification undertaking signed by the company, and the policy bound before the director casts their first real board vote, because that is when liability starts accruing. The mechanics are not slow once people focus: a private company can amend its articles, pass the board and shareholder resolutions, and file the change with the Registrar within a couple of weeks. The usual failure is not legal complexity, it is drift, where everyone agrees the protection should exist and nobody puts it on the agenda until a claim forces the issue. By then, advance indemnification for the events you care about may no longer be available to you.
8. Foreign Directors and the M&A Trap
Two situations expose foreign directors more than locals, and both are avoidable with a little foresight.
The first is cross-border claim risk. A non-resident director gets the same statutory protection an Israeli one does, because the Companies Law makes no distinction by nationality. The weak point is the insurance, not the law. A purely domestic Israeli D&O policy may exclude or fail to respond to a claim brought in your home country, where you might well be sued as the accessible defendant. If you sit on the board of an Israeli company while living in London or New York, confirm in writing that the policy covers claims and proceedings in your jurisdiction, not only in Israel.
The second is the moment the company is sold. Because D&O cover is claims-made, an acquisition can quietly strip a departing director of protection. The buyer takes over, the old policy lapses or is replaced, and a claim filed afterwards about your years in office has nothing to respond to it. The standard fix is run-off (tail) cover, a policy that keeps responding to claims made after closing for acts before it. Run-off is typically arranged for seven years, which lines up with the general limitation period for civil claims under the Limitation Law, 5718-1958. In any sale, run-off cover and the survival of your indemnification rights should be written into the share purchase agreement, not left as an afterthought.
For directors in a sale of an Israeli company, the run-off cover is a deal point that should never be left loose. The share purchase agreement should require the buyer (or the seller, funded from the proceeds) to maintain a seven-year run-off D&O policy for the outgoing directors, and to keep their indemnification undertakings alive for the same period. The cost of a tail is small set against the price of the transaction, and the time to secure it is while the buyer still wants the deal to close. After closing, a former director has almost no leverage. It is not unusual for directors to discover, three years after an exit they thought was clean, that nobody bought the tail and the claim now in front of them is uninsured.